Inozyme Pharma Inc (INZY)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 258.25M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 6.24
52W Low
$ 0.72
Dividend Yield
0.00%
Beta
2.29
Technicals
50-Day MA
3.094
200-Day MA
2.6323
52 Week High
6.24
52 Week Low
0.721
About INZY
Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function.
Employees
67
Headquarters
Boston, MA
CEO
Dr. Douglas A. Treco Ph.D.